UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report
of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16
Under the Securities Exchange Act of 1934
For the Month of July 2018
333-206723
(Commission File Number)
P.V. Nano Cell Ltd.
(Exact name of Registrant as specified in its charter)
8
Hamasger Street
Migdal Ha’Emek, Israel 2310102
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F þ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
On July 24th, 2018, P.V. Nano Cell Ltd. (the “Issuer”) issued a press release announcing entering into a yearlong contract with Emerging Markets Consulting, LLC (“EMC”). EMC specializes in supporting small and Mid cap companies gain exposure with individual investors. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
1 |
Exhibit Index
Exhibit No. | Description | |
99.1 | PV Nano Cell Contracts Investor Relations Services with Emerging Markets Consulting, LLC. |
2 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
P.V. Nano Cell Ltd. | ||
Date July 25th, 2018 | By: | /s/ Dr. Fernando de la Vega |
Name:
Dr. Fernando de la Vega Title: Chief Executive Officer |
3 |